CN112236678B - 用于多发伤患者的创伤相关并发症预后的pro-adm - Google Patents

用于多发伤患者的创伤相关并发症预后的pro-adm Download PDF

Info

Publication number
CN112236678B
CN112236678B CN201980037837.4A CN201980037837A CN112236678B CN 112236678 B CN112236678 B CN 112236678B CN 201980037837 A CN201980037837 A CN 201980037837A CN 112236678 B CN112236678 B CN 112236678B
Authority
CN
China
Prior art keywords
sample
proadm
fragment
level
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201980037837.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN112236678A (zh
Inventor
达留斯·维尔松
阿林·佩拉
斯特凡·埃布迈尔
弗劳克·德赖尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BRAHMS GmbH
Original Assignee
BRAHMS GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BRAHMS GmbH filed Critical BRAHMS GmbH
Publication of CN112236678A publication Critical patent/CN112236678A/zh
Application granted granted Critical
Publication of CN112236678B publication Critical patent/CN112236678B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN201980037837.4A 2018-06-06 2019-06-06 用于多发伤患者的创伤相关并发症预后的pro-adm Active CN112236678B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18176268.3A EP3578989A1 (en) 2018-06-06 2018-06-06 Pro-adm for prognosis of trauma-related complications in polytrauma patients
EP18176268.3 2018-06-06
PCT/EP2019/064805 WO2019234165A1 (en) 2018-06-06 2019-06-06 Pro-adm for prognosis of trauma-related complications in polytrauma patients

Publications (2)

Publication Number Publication Date
CN112236678A CN112236678A (zh) 2021-01-15
CN112236678B true CN112236678B (zh) 2024-10-11

Family

ID=62562975

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980037837.4A Active CN112236678B (zh) 2018-06-06 2019-06-06 用于多发伤患者的创伤相关并发症预后的pro-adm

Country Status (5)

Country Link
US (1) US12560620B2 (https=)
EP (2) EP3578989A1 (https=)
JP (2) JP7548823B2 (https=)
CN (1) CN112236678B (https=)
WO (1) WO2019234165A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102544219B1 (ko) * 2021-08-17 2023-06-14 한림대학교 산학협력단 코펩틴의 농도를 이용한 외상성 뇌 손상의 진단 방법
EP4658247A1 (en) * 2023-01-31 2025-12-10 Vivacelle Bio, Inc. Compositions and methods for treating hyperprocalcitonemia
CN117964711B (zh) * 2024-04-01 2024-06-11 中国科学院生物物理研究所 非天然抗菌肽及其应用
WO2026013199A1 (en) 2024-07-12 2026-01-15 Cezanne S.A.S. Clinical immunoassay with early signal measurement

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017089474A1 (en) * 2015-11-27 2017-06-01 Brahms Gmbh MR-proADM AS MARKER FOR THE EXTRACELLULAR VOLUME STATUS OF A SUBJECT
WO2018029214A1 (en) * 2016-08-09 2018-02-15 B.R.A.H.M.S Gmbh Histones and/or proadm as markers indicating an adverse event

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4882733A (en) 1987-03-13 1989-11-21 Ford Aerospace Corporation Method and apparatus for combining encoding and modulation
FR2664699B1 (fr) 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
DE69602756T2 (de) 1995-08-18 2000-02-10 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Rockville Funktionelle rolle von adrenomedullin(am) und dem gen-verwandten produkt(pamp) in der menschlichen pathologie und physiologie
KR100425525B1 (ko) 2000-11-21 2004-03-30 재단법인서울대학교산학협력재단 조산과 태아감염 및 태아손상을 산전 진단하기 위한진단시약 및 진단키트
DE10316583A1 (de) 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
DE102006034142A1 (de) 2006-07-24 2008-01-31 B.R.A.H.M.S. Aktiengesellschaft Verfahren zur Steuerung der Therapie von Patienten mit Herzinsuffizienz anhand der vitro Bestimmung von Schwellenwerten von vasoaktiven Peptiden
DE102006060112A1 (de) 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
US8298774B2 (en) * 2007-03-12 2012-10-30 Biomedica Medizinprodukte Gmbh & Co Kg Diagnosis of septic complications
PL2185937T5 (pl) * 2007-09-07 2014-12-31 Univ Zuerich Sposób wykrywania posocznicy u ludzi
ES2486268T3 (es) 2007-11-16 2014-08-18 Biocartis Nv Biomarcadores y procedimientos de diagnóstico, predicción y/o pronóstico de septicemia y usos de los mismos
US9229013B2 (en) 2009-05-05 2016-01-05 B.R.A.H.M.S Gmbh Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunction
EP2438447B1 (en) 2009-06-05 2015-02-18 B.R.A.H.M.S GmbH Detection of bacterial infections in subjects suffering from dyspnea.
US8383332B2 (en) 2009-10-13 2013-02-26 B.R.A.H.M.S. Gmbh Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack
EP2545379B1 (en) 2010-03-08 2015-09-30 B.R.A.H.M.S GmbH Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
WO2012059477A1 (en) 2010-11-01 2012-05-10 B.R.A.H.M.S Gmbh Prognosis and risk assessment of patients with non-specific complaints
US10935548B2 (en) 2011-12-08 2021-03-02 Astute Medical, Inc. Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2
EP2976646B1 (en) * 2013-03-20 2020-08-19 sphingotec GmbH Adrenomedullin to guide therapy of blood pressure decline
EP4231018A3 (en) 2016-07-08 2023-11-15 SphingoTec GmbH Adrenomedullin for assessing congestion in a subject with acute heart failure
RU2764766C2 (ru) * 2016-08-09 2022-01-21 Б.Р.А.Х.М.С. Гмбх Гистоны и/или proadm в качестве маркеров, свидетельствующих об органной дисфункции
ES2944613T3 (es) * 2017-02-02 2023-06-22 Brahms Gmbh proADM y/o histonas como marcadores indicadores de un acontecimiento adverso

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017089474A1 (en) * 2015-11-27 2017-06-01 Brahms Gmbh MR-proADM AS MARKER FOR THE EXTRACELLULAR VOLUME STATUS OF A SUBJECT
WO2018029214A1 (en) * 2016-08-09 2018-02-15 B.R.A.H.M.S Gmbh Histones and/or proadm as markers indicating an adverse event

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study;Philipp Schuetz et al;《Critical Care》;第第19卷卷;第1-11页 *
Prediction about severity and out come of sepsis by proatrial natriuretic peptide and pro-adrenomedullin;wANGRuilan et al;《Chinese Journal of Traumatology 》;第第13卷卷(第第3期期);第152-157页 *

Also Published As

Publication number Publication date
EP3803417A1 (en) 2021-04-14
WO2019234165A1 (en) 2019-12-12
US20210405070A1 (en) 2021-12-30
CN112236678A (zh) 2021-01-15
JP2021525879A (ja) 2021-09-27
EP3578989A1 (en) 2019-12-11
JP7548823B2 (ja) 2024-09-10
US12560620B2 (en) 2026-02-24
JP2024091650A (ja) 2024-07-05

Similar Documents

Publication Publication Date Title
CN112236678B (zh) 用于多发伤患者的创伤相关并发症预后的pro-adm
JP7344208B2 (ja) ｐｒｏ－ＡＤＭに基づく抗生物質療法の指導
JP2024023615A (ja) 感染性疾患の症状を有する患者において入院を必要とする病状のリスクを予測するためのｐｒｏ－ａｄｍ
US20230160893A1 (en) Pro-adrenomedullin for prognosing disease progression in severe acute respiratory syndrome (sars)
US20240393352A1 (en) Antibiotic therapy guidance based on procalcitonin in patients with comorbidities
CN111065927B (zh) 作为危重患者的治疗监测标记物的pro-adm
JP7258860B2 (ja) 抗生物質治療をモニタリングするためのマーカーとしてのｐｃｔおよびｐｒｏ－ａｄｍ
US20260056215A1 (en) Pro-ADM for Prognosis of Trauma-Related Complications in Polytrauma
RU2820944C2 (ru) Проадм для прогнозирования риска состояния, требующего госпитализации, у пациентов с симптомами инфекционного заболевания
RU2782305C2 (ru) Про-адм в качестве маркера мониторинга терапии для критически больных пациентов
HK40030378A (zh) 基於pro-adm的抗生素疗法指导
HK40029756B (zh) 使用降钙素原和中区肾上腺髓质素原的风险评估和患者管理的工作流程

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant